Moshe Arkin - 18 Mar 2026 Form 3 Insider Report for Sol-Gel Technologies Ltd. (SLGL)

Role
Chairman of Board and CEO, Director, 10%+ Owner
Signature
/s/Eyal Ben-Or, Attorney-in-Fact
Issuer symbol
SLGL
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 12:12:48 UTC
Previous filing
10 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arkin Moshe Chairman of Board and CEO, Director, 10%+ Owner C/O SOL-GEL TECHNOLOGIES LTD., 7 GOLDA MEIR STREET, NESS ZIONA, ISRAEL /s/Eyal Ben-Or, Attorney-in-Fact 18 Mar 2026 0001321178

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SLGL Ordinary Shares 143,257 18 Mar 2026 Direct F1
holding SLGL Ordinary Shares 1,606,856 18 Mar 2026 By M. Arkin Dermatology Ltd. F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SLGL Warrants (right to buy) 18 Mar 2026 Ordinary Shares 200,000 $58.50 By M. Arkin Dermatology Ltd. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ordinary shares, NIS 1.00 par value per share.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit 24 - Power of Attorney